481 research outputs found
Hydatothrips longirostris Rachana & Amarendra & Vanitha 2023, sp. n.
No full text<i>Hydatothrips longirostris</i> sp. n. <p>(Figs 1–14)</p> <p> <i>Female macroptera.</i> Body bicoloured (Fig. 1); head and pterothorax brown; pronotum yellow with blotch scarcely distinguishable from the rest; metanotum pale at posterior third; abdominal segment I yellow with lateral third brown and antecostal ridge interrupted medially, II–III & VI brown with pale median area, IV–V & VII–X yellow; antecostal ridges on tergites II–VII complete and dark brown; antennal segments I–IV yellow, V yellow with apical brown infusion, VI–VIII brown. Fore wing banded with sub-basal, median and apical pale areas in contrast to three brown bands, basal ¾ of clavus brown (Fig. 7); all femora, tibiae and tarsi yellow with brown infusion. Antennae 8-segmented, segments III and IV each with forked sense cones and reaching to the basal 1/5 of the next segment (Fig. 3). Head wider than long, sculpture lines within ocellar triangle, with internal markings; occipital apodeme touching posterior margin of eyes; ocellar setae III placed outside ocellar triangle, touching inner margin of eyes; post-occipital area with transverse striations; three pairs of postocular setae along posterior inner margin of eyes, median pair long, longer than ocellar setae III and the rest sub equal (Fig. 6); mouth cone unusually long, extending to metasternum (Fig. 8). Pronotum transversely reticulate with internal markings in front of blotch area; blotch not defined except for anterior apodeme; second posteromarginal setae (S2) very stout, prominent and the longest; short posteroangular setae (Fig. 4). Mesonotum transversely striate, with internal markings, median pair of setae ahead of sub-median pair well anterior to posterior margin (Fig. 5). Metanotum sculptured transversely anteromedially, longitudinally at each side, irregularly reticulate at median posterior third, with internal markings; median setae a little behind anterior margin (Fig. 5). Metasternal plate with deep U- shaped invagination (Fig. 8). Fore wing first vein with about 20–21 setae, second vein with 2 setae (Fig. 7). Abdominal tergites I–VI medially without marginal microtrichia (Fig. 10); VII medially with minute marginal microtrichia (Fig. 11); VIII with complete posteromarginal comb of long microtrichia (Fig. 14); tergites I–VIII with rows of dense microtrichia laterally, I without median discal microtrichia, II–VI with discal microtrichia medially restricted to anterior one third (Fig. 10), VII–VIII almost fully covered with discal mirotrichia (Figs 11 & 14); IX with no discal microtrichia; X with discal microtrichia posteriorly (Fig. 9); tergal median setae situated at antecostal ridges; tergites II–VIII with setae S3 positioned at posterior margin, with 3–4 setae lateral to S3 (Figs 10, 11 & 14); tergite IX with asymmetric arrangement of mid-dorsal setae i.e. 4 pairs on one side and 3 pairs on the other side (Fig. 9). Abdominal sternites without discal setae; II–VI completely covered with discal microtrichia, posterior margin with complete comb of microtrichia interrupted only at setal bases. Ovipositor very long and well developed.</p> <p> <b>Measurements</b> (holotype female in microns). Body length 1100. Head, length 60; width across eyes 130; ocellar setae III 12; postocular setae I 17. Pronotum, length 105; width 175. Fore wing length 640. Antennal segments III–VIII length 62, 62, 47, 55, 7, 17.</p> <p> <i>Male macroptera.</i> Similar to female, but smaller in size (Fig. 2); sternites III–VII with elongated transverse pore plate (Fig. 12).</p> <p> <b>Measurements</b> (paratype male in microns). Body length 920. Head, length 55; width across eyes 130; ocellar setae III 10; postocular setae I 17. Pronotum, length 90; width 155. Fore wing length 480. Antennal segments III–VIII length 50, 50, 40, 45, 7, 12.</p> <p> <b>Material studied.</b> Holotype female, <b>INDIA</b>, Karnataka, Mangalore, Puttur, collected on leaves of <i>Getonia floribunda</i> (Combretaceae) (Fig. 15), 24.iii.2023 (K. Vanitha) (ICAR / NBAIR / THYS /24032023). Paratypes: 8 females and 6 males with same data as holotype except 5 paratype females with mouthcone reaching up to metathoraxic coxa and one paratype female with 4 pairs of mid-dorsal setae on both sides of abdominal segment IX. Holotype and paratypes deposited in the National Insect Museum, National Bureau of Agricultural Insect Resources (ICAR-NBAIR), Bengaluru, India.</p> <p> <b>Etymology:</b> The species name <i>longirostris</i>, meaning “long rostrum’’, is in reference to the unusually long mouth cone of this species.</p> <p> <b>Comments:</b> This species is interesting in having an elongated mouth cone, a character state also known in a few species of the genus <i>Neohydatothrips</i> John, <i>N. abditus</i> (Hartwig), <i>N. barrowi</i> Mound & Tree, <i>N. catenatus</i> (Hood), <i>N. lepidus</i> (Faure), <i>N. mundus</i> (Hartwig), and <i>N. gracilipes</i> (Hood) (Lima & Mound 2016b). Mouth cone of this species extends beyond the mesothoracic coxae (reaching the metathoraxic coxae in many paratypes), probably longer than in any described <i>Hydatothrips</i> species. Only <i>H. longjingensis</i> Mirab-balou <i>et al.</i> and <i>H. ormocarpi</i> (Faure) have long mouth cone, however, it only reaches to the posterior margin of pronotum (Faure 1962; Mirab-balou <i>et al.</i> 2011). Besides, it is separable from the other members of the genus by the following character combinations: ocellar setae III placed outside ocellar triangle; pronotum yellow without a well-defined blotch except for anterior apodeme; fore wing banded, second vein with 2 setae; abdominal sternites II–VI completely covered with discal microtrichia, posterior margin with complete comb of microtrichia interrupted only at setal bases; abdominal sternites III–VII of male with elongate transverse pore plate.</p>Published as part of <i>Rachana, R. R., Amarendra, B. & Vanitha, K., 2023, A new species of Hydatothrips (Thysanoptera, Thripidae) from India with one new record, pp. 589-594 in Zootaxa 5319 (4)</i> on pages 590-592, DOI: 10.11646/zootaxa.5319.4.9, <a href="http://zenodo.org/record/8221937">http://zenodo.org/record/8221937</a>
Hydatothrips Karny 1913
No full text<i>Hydatothrips</i> Karny <p> The members of this genus are predominantly bicoloured. The genus <i>Hydatothrips</i> can be distinguished from other genera of Sericothripinae by the available keys (Lima & Mound 2016a & b). <i>Hydatothrips</i> is characterized by the anterior margin of the metasternal plate with deep U- or V-shaped invagination.</p>Published as part of <i>Rachana, R. R., Amarendra, B. & Vanitha, K., 2023, A new species of Hydatothrips (Thysanoptera, Thripidae) from India with one new record, pp. 589-594 in Zootaxa 5319 (4)</i> on page 590, DOI: 10.11646/zootaxa.5319.4.9, <a href="http://zenodo.org/record/8221937">http://zenodo.org/record/8221937</a>
Dendrothrips glynn Mound
No full text<i>Dendrothrips glynn</i> Mound <p>(Figs 16–25)</p> <p>Described from Australia from tree flowers (Mound 1999), this species of Dendrothripinae is here recorded from India for the first time based on the following specimens: Tamil Nadu, Dindigal, Thadiyankudisai, 6 females, collected in yellow pan traps, 27.i.2017 (Gandhi Gracy R.).</p> <p> <b> <i>Diagnosis</i>:</b> Head, pronotum and pterothorax light brown (Fig. 16), abdomen yellow with two pairs of small brown spots on tergites II–VII (Fig. 19); fore wing pale, with three short, transverse light brown bands, apex weakly shaded (Fig. 25). Head transverse, reticulate within ocellar triangle with internal markings; ocellar pair III outside ocellar triangle anterior to hind ocelli (Fig. 21). Antennae 7- segmented (Fig. 17). Pronotum irregularly reticulate with internal markings (Fig. 20). Metanotum reticulate with minute tubercles inside (Fig. 18). Abdominal tergites each with anterior reticulations and posterior longitudinal ridges; VIII with a few median slender microtrichia (Fig. 23). Sternites reticulate (Fig. 24).</p>Published as part of <i>Rachana, R. R., Amarendra, B. & Vanitha, K., 2023, A new species of Hydatothrips (Thysanoptera, Thripidae) from India with one new record, pp. 589-594 in Zootaxa 5319 (4)</i> on page 593, DOI: 10.11646/zootaxa.5319.4.9, <a href="http://zenodo.org/record/8221937">http://zenodo.org/record/8221937</a>
Performance evaluation of geopolymer masonry units: A hybrid approach combining laboratory testing and AI modeling
No full textThis study presents a comprehensive investigation into the compressive strength and stress–strain behavior of geopolymer brick masonry, focusing on both prisms and wallettes. Geopolymer bricks and mortars were used to fabricate specimens, and their mechanical performance was experimentally evaluated. The study also employs nine machine learning algorithms on a dataset comprising 612 prism and 63 wallette data points, assessing performance based on six predictive metrics. Experimental results revealed that prisms exhibited higher compressive strength (7.2 MPa to 2.6 MPa) compared to wallettes (6.5 MPa to 1.2 MPa), with a linear regression indicating wallettes achieve approximately 88 % of prism strength. Among the ML models, Random Forest performed best, with R2 values of 0.92 and 0.97 for prism and wallette datasets, respectively. The results emphasize the influence of brick-and-mortar properties and dimensional parameters on masonry performance. This study advances the understanding of geopolymer masonry and demonstrates the synergy of experimental analysis and machine learning for predictive modeling in sustainable construction
Vitamin K supplementation for cystic fibrosis (Review)
No full textBackground: Cystic fibrosis is a genetic disorder which can lead to multiorgan dysfunction. Malabsorption of fat and fat-soluble vitamins (A, D, E, K) may occur and can cause subclinical deficiencies of some of these vitamins. Vitamin K is known to play an important role in both blood coagulation and bone formation. Supplementation with vitamin K appears to be one way of addressing the deficiency, but there is very limited agreement on the appropriate dose and frequency of use of these supplements. Objectives: To assess the effects of vitamin K supplementation in people with cystic fibrosis and to determine the optimal dose and route of administration of vitamin K for both routine and therapeutic use. Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register comprising references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. Most recent search: 11 October 2012. Selection criteria: Randomised and quasi-randomised controlled trials of all preparations of vitamin K used as a supplement compared to either no supplementation (or placebo) at any dose or route and for any duration, in children or adults diagnosed with cystic fibrosis (by sweat test or genetic testing). Data collection and analysis: Two authors independently screened papers, extracted trial details and assessed their risk of bias. Main results: Two trials (total of 32 participants) were included in the review and were assessed as having a moderate risk of bias. One was a dose-ranging parallel group trial; and the other had a cross-over design, but no separate data were reported for the first intervention period. Neither of the trials addressed any of the primary outcomes (coagulation, bone formation and quality of life). Both trials reported the restoration of serum vitamin K and undercarboxylated osteocalcin levels to the normal range after one month of daily supplementation with 1 mg of vitamin K. Authors' conclusions: Evidence from randomised controlled trials on the benefits of routine vitamin K supplementation for people with CF is currently weak and limited to two small trials of short duration. However, no harm was found and until further evidence is available, the present recommendations should be adhered to
Vitamin K supplementation for cystic fibrosis.
No full textBACKGROUND: Cystic fibrosis is a genetic disorder which can lead to multiorgan dysfunction. Malabsorption of fat and fat-soluble vitamins (A, D, E, K) may occur and can cause subclinical deficiencies of some of these vitamins. Vitamin K is known to play an important role in both blood coagulation and bone formation. Supplementation with vitamin K appears to be one way of addressing the deficiency, but there is very limited agreement on the appropriate dose and frequency of use of these supplements. OBJECTIVES: To assess the effects of vitamin K supplementation in people with cystic fibrosis and to determine the optimal dose and route of administration of vitamin K for both routine and therapeutic use. SEARCH STRATEGY: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register comprising references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.Most recent search: 15 April 2010. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials of all preparations of vitamin K used as a supplement compared to either no supplementation (or placebo) at any dose or route and for any duration, in children or adults diagnosed with cystic fibrosis (by sweat test or genetic testing). DATA COLLECTION AND ANALYSIS: Two authors independently screened papers, extracted trial details and assessed their risk of bias. MAIN RESULTS: Two trials (total of 32 participants) were included in the review and were assessed as having a moderate risk of bias. One was a dose-ranging parallel group trial; and the other had a cross-over design, but no separate data were reported for the first intervention period. Neither of the trials addressed any of the primary outcomes (coagulation, bone formation and quality of life). Both trials reported the restoration of serum vitamin K and undercarboxylated osteocalcin levels to the normal range after one month of daily supplementation with 1 mg of vitamin K. AUTHORS' CONCLUSIONS: Evidence from randomised controlled trials on the benefits of routine vitamin K supplementation for people with CF is currently weak and limited to two small trials of short duration. However, no harm was found and until further evidence is available, the present recommendations should be adhered to
Vitamin K supplementation for cystic fibrosis (Review)
No full textBackgroundCystic fibrosis is a genetic disorder which can lead to multiorgan dysfunction. Malabsorption of fat and fat-soluble vitamins (A, D, E, K) may occur and can cause subclinical deficiencies of some of these vitamins. Vitamin K is known to play an important role in both blood coagulation and bone formation. Supplementation with vitamin K appears to be one way of addressing the deficiency, but there is very limited agreement on the appropriate dose and frequency of use of these supplements.Objectives To assess the effects of vitamin K supplementation in people with cystic fibrosis and to determine the optimal dose and route of administration of vitamin K for both routine and therapeutic use.Search methodsWe searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Register comprising references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. Most recent search: 08 October 2014.Selection criteriaRandomised and quasi-randomised controlled trials of all preparations of vitamin K used as a supplement compared to either no supplementation (or placebo) at any dose or route and for any duration, in children or adults diagnosed with cystic fibrosis (by sweat test or genetic testing).Data collection and analysisTwo authors independently screened papers, extracted trial details and assessed their risk of bias.Main resultsTwo trials (total of 32 participants) each lasting one month were included in the review and were assessed as having a moderate risk of bias. One was a dose-ranging parallel group trial in children (aged 8 to 18 years); and the other (with an older cohort) had a crossover design comparing supplements to no treatment, but no separate data were reported for the first intervention period. Neither of the trials addressed any of the primary outcomes (coagulation, bone formation and quality of life). Both trials reported the restoration of serum vitamin K and undercarboxylated osteocalcin levels to the normal range after one month of daily supplementation with 1 mg of vitamin K.Authors' conclusionsEvidence from randomised controlled trials on the benefits of routine vitamin K supplementation for people with CF is currently weak and limited to two small trials of short duration. However, no harm was found and until further evidence is available, the present recommendations should be adhered to
Characterization of active component in the given probiotic lactic acid bacteria against V. cholerae
No full textThis Dissertation / Report is the outcome of investigation carried out by the creator(s) / author(s) at the department/division of Central Food Technological Research Institute (CFTRI), Mysore mentioned below in this page
Cultural Diversity in Dramatherapy in the Malaysian Context
No full text This paper discusses the practice of dramatherapy in the past 4 years in the Malaysian context. Malaysia is a culturally diverse country. There are three different ethnicities in Malaysia: Malays, Chinese and Indians. The most common religions practiced in Malaysia include Islam, Buddhism, Christianity, and Hinduism. In the past decades there have been migrations from other Asian countries, as well as an increase in foreign students and expatriates. This paper discusses the different perceptions and reactions of clients of these various ethnic, cultural and religious backgrounds. The author discusses the reactions of the employing organization, when she used Hindu mythology in a country where the official religion is Islam. Some of her work with international students, who bring a different set of cultural issues and richness to dramatherapy, is also explored. The author is Malaysian, trained as a dramatherapist in the UK, then returned to establish dramatherapy practice in her birth country. </jats:p
- …
